TickerFactsScreenerDevelopers

Evofem Biosciences, Inc. (EVFM) — Operating Income

Annual figures by fiscal year, from SEC filings.

2013: -$14.42M2014: -$9.59M2015: -$42.05M2016: -$12.04M2017: -$35.69M2018: -$77.64M2019: -$52.74M2020: -$103.62M2021: -$166.80M2022: -$84.12M2023: -$17.85M2024: -$7.68M2025: $3.37M$3.37M
2013Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025$3.37M+143.9%
2024-$7.68M+57.0%
2023-$17.85M+78.8%
2022-$84.12M+49.6%
2021-$166.80M-61.0%
2020-$103.62M-96.5%
2019-$52.74M+32.1%
2018-$77.64M-117.6%
2017-$35.69M-196.3%
2016-$12.04M+71.4%
2015-$42.05M-338.4%
2014-$9.59M+33.5%
2013-$14.42M—